Albuquerque Express
AlbuquerqueExpress.com Thursday 11th March 2010 Volume 070/8
  • More Breaking Business News

  • Forbes says Gates no longer the world's richest
  • Sri Lanka doing massive deals with China
  • Chrysler takes Volkswagen exec to run Fiat
  • BA strike to go ahead after talks failure
  • Carlos Slim becomes the new Bill Gates
  • Defects unable to stop Toyota sales in US
  • UK bank has better time in 2009
  • Russia goes to Argentina for caviar fix
  • Orange County residents can now go direct to the islands
  • Emaar Properties to go ahead with Lombok proposal
  • Another Toyota runs away from driver
  • Asia free-trade agreements attract Americans
    Get Breaking Business News headlines emailed to you daily.

    Johnson & Johnson accused of unfair drug promotion
    Albuquerque Express
    Sunday 17th January, 2010  


    The US government has alleged in a lawsuit that Johnson & Johnson made a monetary agreement with US pharmacy group Omnicare to promote its antipsychotic drug Risperdal for elderly patients.
    The US government has alleged in a lawsuit that Johnson & Johnson made a monetary agreement with US pharmacy group Omnicare to promote its antipsychotic drug Risperdal for elderly patients.

    A Justice Department summary on the lawsuit says Johnson & Johnson paid Omnicare, which is the largest US pharmacy for nursing homes, to promote certain drugs, including Risperdal.

    Johnson & Johnson Health Care Systems and its subsidiary Ortho-McNeil-Janssen Pharmaceuticals have been accused of paying millions of dollars in kickbacks to Omnicare.

    The government is alleging that J&J turned Omnicare's pharmacists into a de facto sales-force, as they had the responsibility of making recommendations to physicians on what drugs should be prescribed for patients of nursing homes.

    It has been suggested by prosecutors that the physicians accepted the Omnicare pharmacists' recommendations more than 80 percent of the time.

      Email this story to a friend

    Have your say on this story

    Your nickname (optional)
    Message